Johnson & johnson (JNJ)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Apr'18Dec'17Sep'17Jun'17Mar'17Jan'17Sep'16Jun'16Mar'16Jan'16Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss) Attributable to Parent

5,796

4,010

1,753

5,607

3,749

3,042

3,934

3,954

4,367

-10,713

3,764

3,827

4,422

3,814

4,272

3,997

4,457

-

3,358

4,516

4,320

2,521

4,749

4,326

4,727

3,519

2,982

3,833

3,497

2,567

2,629

1,408

3,910

218

3,202

2,776

3,476

1,942

3,417

3,449

4,526

2,206

3,345

3,208

3,507

Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles

1,747

1,816

1,727

1,705

1,761

1,735

1,731

1,717

1,746

1,869

1,711

1,150

912

1,055

908

900

891

-

929

889

895

991

939

952

1,013

1,102

976

990

1,036

1,036

1,005

852

773

843

783

777

755

769

725

711

734

744

675

679

676

Stock based compensation

263

160

245

314

258

156

242

312

268

204

236

293

229

174

225

274

205

-

203

270

204

146

206

242

198

144

161

229

194

147

146

196

173

137

145

187

152

140

169

148

157

129

158

182

159

Venezuela adjustments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

108

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Asset write-downs

11

77

30

76

913

32

1,199

27

0

486

39

233

37

96

0

105

82

-

356

11

0

151

87

135

37

492

178

0

69

84

679

1,368

0

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration reversal

-983

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net gain on sale of assets/businesses

0

29

46

2,007

72

774

0

443

0

-

-

-

-

-

-

-

-

-

240

996

38

47

2,004

332

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax provision

54

-350

-1,432

-332

-362

-1,069

338

-329

44

2,813

-335

-45

-27

-556

100

-278

393

-

-51

-261

545

144

-296

98

495

-383

-316

-273

365

285

187

-1,068

557

13

-345

-500

-4

-288

40

-356

960

-977

-104

-567

1,212

Accounts receivable allowances and credit losses

22

-5

-16

4

-3

-28

13

4

-20

-42

35

37

-13

-1

-6

-3

-1

-

-3

26

-21

26

-17

-12

-25

-99

-3

-18

-11

6

3

41

42

53

12

-17

-16

-18

-16

-32

78

19

-13

30

22

Changes in assets and liabilities, net of effects from acquisitions and divestitures:
(Increase) / Decrease in accounts receivable

812

-376

329

493

-157

145

51

510

479

333

-176

380

96

329

-362

709

389

-

-276

421

765

-152

-185

158

426

-339

324

213

434

103

61

-370

215

426

-87

-33

609

-378

30

26

529

-514

-164

311

-86

Increase in inventories

159

-147

1

54

369

-133

286

169

322

-774

-228

53

368

-159

-35

253

190

-

182

261

276

22

493

93

512

-177

252

259

288

-592

-25

169

449

-72

167

168

452

-1

109

-105

193

-345

-89

675

-336

Decrease in accounts payable and accrued liabilities

-2,523

1,787

2,717

1,389

-1,833

3,220

780

1,637

-1,686

2,386

1,540

829

-2,030

1,876

-173

1,025

-2,072

-

660

520

-2,451

2,021

-232

409

-1,004

1,232

1,304

744

-1,459

1,548

321

2,230

-1,331

593

344

683

-1,127

1,572

167

-68

-1,651

1,323

67

258

-2,155

Decrease / (Increase) in other current and non-current assets

-271

973

-781

374

488

-629

637

-640

907

-144

14

117

424

-532

-280

-8

802

-

-384

-1,164

562

-370

-636

412

152

1,345

-34

-226

608

474

278

-242

754

719

-14

110

970

264

-394

-384

1,088

-1,244

7

67

-39

Decrease in other current and non-current liabilities

-329

-618

2,098

113

-168

-687

-991

-761

595

9,297

-640

51

271

120

-551

-317

-385

-

450

15

1,021

-1,847

868

311

-428

-944

1,186

248

-192

-1,404

-15

-1,225

89

2,667

547

88

1,111

-408

277

-478

696

-260

720

-296

-133

NET CASH FLOWS FROM OPERATING ACTIVITIES

3,358

6,398

7,527

5,948

3,543

6,244

6,272

6,079

3,606

6,105

6,266

5,772

2,913

6,653

5,361

4,564

2,189

-

6,140

5,472

2,872

4,604

4,654

5,529

3,923

4,139

5,947

5,051

2,277

3,376

4,980

4,245

2,795

3,451

4,622

3,909

2,316

3,824

5,034

3,837

3,690

5,287

5,094

3,363

2,827

CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment

625

1,260

745

837

656

1,318

819

875

658

1,240

790

689

560

1,093

737

757

639

-

789

765

543

1,496

751

837

630

1,429

809

771

586

1,152

682

598

502

1,128

711

618

436

959

528

500

397

844

519

567

435

Proceeds from the disposal of assets/businesses, net

17

162

85

2,765

253

2,308

25

850

20

1,106

601

94

31

394

188

660

25

-

427

1,083

110

150

3,908

538

35

266

45

41

106

604

215

332

358

621

578

22

121

200

215

7

102

142

0

6

6

Acquisitions, net of cash acquired

939

238

216

3,663

1,683

3

675

140

82

554

574

29,220

4,852

459

3,320

725

5

-

0

0

233

1,838

291

0

0

16

645

6

168

63

99

4,324

0

328

420

0

2,049

0

398

99

772

133

1,046

0

1,291

Purchases of investments

2,064

1,236

1,167

787

730

1,471

3,204

403

548

355

571

677

4,550

6,273

10,166

7,449

10,062

-

7,953

13,651

7,162

9,129

8,432

11,925

5,427

5,340

5,014

5,018

3,551

4,597

3,626

2,813

2,398

4,438

8,624

15,784

1,036

5,109

3,984

3,449

3,246

4,118

2,437

2,045

1,440

Sales of investments

1,544

928

327

637

1,495

3,127

419

402

341

606

191

18,326

8,994

5,343

11,662

9,630

9,145

-

7,338

9,779

6,050

9,543

6,354

4,145

4,077

5,167

4,894

5,197

2,800

2,663

2,251

3,283

6,600

11,958

7,856

5,685

4,897

4,432

2,869

1,360

2,440

2,535

2,226

321

2,150

Proceeds from credit support agreements, net

1,743

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

257

28

-71

-97

96

416

15

35

-2

117

37

81

-1

86

-1

37

1

-

24

0

11

152

53

13

81

226

24

12

4

-42

-4

6

2

447

269

5

57

-32

49

12

9

-54

79

18

66

NET CASH USED BY INVESTING ACTIVITIES

-581

-1,344

-1,645

-1,788

-1,417

2,228

-4,269

-201

-925

-505

-1,180

-12,247

-936

-2,174

-2,372

1,322

-1,537

-

-1,001

-3,554

-1,789

-2,922

735

-8,092

-2,026

-1,578

-1,553

-569

-1,403

-2,503

-1,937

-4,126

4,056

6,238

-1,590

-10,700

1,440

-1,404

-1,875

-2,693

-1,882

-2,364

-1,855

-2,303

-1,076

CASH FLOWS FROM FINANCING ACTIVITIES
Dividends to shareholders

2,505

2,500

2,499

2,522

2,396

2,411

2,415

2,415

2,253

2,256

2,254

2,262

2,171

2,170

2,185

2,197

2,069

-

2,076

2,079

1,946

1,956

1,967

1,978

1,867

1,862

1,862

1,856

1,706

1,690

1,683

1,676

1,565

1,555

1,558

1,563

1,480

1,481

1,484

1,489

1,350

1,353

1,351

1,350

1,273

Repurchase of common stock

1,711

426

1,628

2,486

2,206

3,808

471

145

1,444

815

311

1,890

3,342

2,025

2,203

2,362

2,389

-

300

896

2,198

2,743

2,415

1,192

774

488

3,050

0

0

0

0

12,852

67

853

743

494

435

1,285

732

397

383

958

49

289

834

Proceeds from short-term debt

10

-109

133

2

13

40

13

1

26

-3,891

2,125

1,916

719

-38

31

23

95

-

1,083

435

589

1,234

-1,039

1,390

278

-359

88

1,207

475

-338

1,088

971

1,547

2,513

3,630

-58

3,644

5,978

940

241

715

5,581

821

-194

3,276

Repayment of short-term debt

18

13

75

-4

16

114

-68

-51

2,484

394

756

-15

195

-1,909

-761

515

4,172

-

585

152

193

-446

647

-209

1,275

-19

142

570

704

395

1,000

2,990

1,790

1,156

3,850

3,450

2,744

1,175

1,792

555

3,043

2,779

2,681

274

1,057

Proceeds from long-term debt, net of issuance costs

-

-

-

-

-

-1

3

1

2

4,527

1

0

4,464

53

0

4,516

7,435

-

0

0

3

2,081

4

-3

16

3,556

45

0

6

29

10

4

2

-1

67

4,396

8

-

-

-

-

0

0

7

2

Repayment of long-term debt

11

1,815

3

3

1,002

645

901

1

8

753

1,009

13

2

1,270

17

922

14

-

6

5

16

57

10

1,756

21

62

27

1,503

1

8

786

-20

30

4

7

2

3

11

9

4

8

-5

208

7

9

Proceeds from the exercise of stock options/employee withholding tax on stock awards, net

332

374

117

369

94

469

318

96

66

208

135

317

402

77

183

419

510

-

44

-78

584

137

358

462

586

378

429

719

1,123

903

669

268

880

300

229

532

185

541

299

139

247

582

226

47

27

Other

-412

415

62

101

-3

81

-92

-262

125

-163

0

0

-25

0

-15

0

0

-

0

0

-50

0

0

0

0

0

0

26

30

28

49

0

-160

0

0

0

0

-

-

-

-

-

-

-

-

NET CASH USED BY FINANCING ACTIVITIES

-4,315

-4,072

-3,893

-4,534

-5,516

-6,389

-3,477

-2,674

-5,970

-3,537

-2,069

-1,917

-150

-3,464

-3,445

-1,038

-604

-

-1,840

-2,775

-3,227

-858

-5,716

-2,868

-3,057

1,182

-4,519

-1,977

-777

-1,471

-1,653

-16,255

-1,183

-756

-2,232

-639

-825

2,606

-1,699

-2,065

-3,822

1,078

-3,242

-2,060

132

Effect of exchange rate changes on cash and cash equivalents

-237

74

-116

16

17

-32

-39

-274

104

40

106

81

110

-248

21

-69

81

-

-299

-492

-391

-119

-91

-55

-45

-20

22

-53

-153

23

54

-89

57

-8

-157

48

70

-9

165

-109

-53

-47

173

97

-62

Decrease in cash and cash equivalents

-1,775

1,056

1,873

-358

-3,373

2,051

-1,513

2,930

-3,185

2,103

3,123

-8,311

1,937

767

-435

4,779

129

93

3,000

-1,349

-2,535

705

-418

-5,486

-1,205

3,723

-103

2,452

-56

-575

1,444

-16,225

5,725

8,925

643

-7,382

3,001

5,017

1,625

-1,030

-2,067

3,954

170

-903

1,821

Acquisitions
Fair value of assets acquired

1,136

367

117

4,590

2,154

1

712

215

119

443

333

30,911

5,250

492

3,350

737

7

-

0

1

476

1,862

305

0

0

16

820

6

186

41

116

18,868

0

336

441

3

2,245

-

-

-

-

-

-

-

-

Fair value of liabilities assumed and noncontrolling interests

197

119

-99

927

471

-49

37

75

37

-48

-241

1,691

398

33

30

12

2

-

0

1

243

24

14

0

0

0

175

0

18

-22

17

1,209

0

8

21

3

196

-

-

-

-

-

-

-

-

Net cash paid for acquisitions

939

248

216

3,663

1,683

2

675

140

82

505

574

29,220

4,852

459

3,320

725

5

-

0

0

233

1,838

291

0

0

16

645

6

168

63

99

17,659

0

328

420

0

2,049

-

-

-

-

-

-

-

-

Auris Health
Contingent consideration reversal

-983

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-